Indication

Meningococcal meningitis

Meningococcal meningitis is a severe, life-threatening bacterial infection of the meninges—the protective membranes covering the brain and spinal cord—caused by *Neisseria meningitidis* (meningococcus). Read more about Meningococcal meningitis

127 drugs 59 manufacturers

Advertisement

Drugs that treat it

Common Meningococcal meningitis therapies.

Showing 64–72 of 127 drugs

MEROPENEM

MENINGOCOCCAL MENINGITIS·+21
APP/FRESENIUS K
Filter & compare in the drug finder →Opens the drug finder with Meningococcal meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Meningococcal meningitis.

Meningococcal meningitis is a severe, life-threatening bacterial infection of the meninges—the protective membranes covering the brain and spinal cord—caused by *Neisseria meningitidis* (meningococcus).

While the infection can affect individuals of any age, it disproportionately impacts infants, adolescents, young adults living in congregate settings, and immunocompromised patients.

Pathophysiologically, the organism colonizes the nasopharyngeal mucosa, crosses into the bloodstream, and penetrates the blood-brain barrier to trigger marked subarachnoid inflammation and elevated intracranial pressure.

It classically presents with an acute onset of high fever, severe headache, nuchal rigidity, photophobia, altered mental status, and potentially an accompanying petechial or purpuric rash.

Personalize your experience

Follow Meningococcal meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it